Digoxin for the Reinduction of Radioiodine Uptake in Metastatic or Locally Advanced Non-medullary Thyroid Carcinoma

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

December 6, 2022

Primary Completion Date

June 21, 2023

Study Completion Date

January 1, 2024

Conditions
Non-Medullary Thyroid Carcinoma
Interventions
DRUG

Digoxin tablet

"Participants will be treated with digoxin tablets for 3 weeks. On the first they, participants will start with a starting dosage of 3x0.25mg with 6 hours between each administration. Thereafter they will continue with a dosage of 1x0.25mg. Participants aged \>70 years or with body weight \<55kg will initiate a starting dosage of 3x0.125mg with 6 hours between each administration. Thereafter they will continue with a dosage of 1x0.125mg.~After one week the blood concentration of digoxin will be measured. According to this blood concentration, the dose of digoxin will be adjusted."

Trial Locations (1)

Unknown

Radboud University Medical Center, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER